The surface properties of nanoparticles determine the agglomeration state and the size of the particles under physiological conditions

• Christoph Bantz,
• Olga Koshkina,
• Thomas Lang,
• Hans-Joachim Galla,
• C. James Kirkpatrick,
• Roland H. Stauber and
• Michael Maskos

Beilstein J. Nanotechnol. 2014, 5, 1774–1786, doi:10.3762/bjnano.5.188

• . Hence, they are highly suitable for tailored biomedical applications, for example, as drug carrier systems, as agents in hyperthermia, or as contrast agents for magnetic resonance imaging (MRI) [52][53]. Silica nanoparticles: As most of the common crystalline SiO2 particles are not in the nanometer-size